Treatment failure and miltefosine susceptibility in dermal leishmaniasis caused by Leishmania subgenus Viannia species.

Treatment failure and miltefosine susceptibility in dermal leishmaniasis caused by Leishmania subgenus Viannia species.

Item
http://www.wikidata.org/entity/Q37544280
A Luciferase-Expressing Leishmania braziliensis Line That Leads to Sustained Skin Lesions in BALB/c Mice and Allows Monitoring of Miltefosine Treatment OutcomeMiltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in ColombiaDiagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasisCombined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum.Imipramine alters the sterol profile in Leishmania amazonensis and increases its sensitivity to miconazole.Functional Validation of ABCA3 as a Miltefosine Transporter in Human Macrophages: IMPACT ON INTRACELLULAR SURVIVAL OF LEISHMANIA (VIANNIA) PANAMENSIS.Antileishmanial Activity of Ezetimibe: Inhibition of Sterol Biosynthesis, In Vitro Synergy with Azoles, and Efficacy in Experimental Cutaneous LeishmaniasisSusceptibility to Miltefosine in Brazilian Clinical Isolates of Leishmania (Viannia) braziliensis.Chemotherapy of leishmaniasis: present challenges.Susceptibility Testing of Medically Important Parasites.Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum.Detection and identification of Leishmania spp.: application of two hsp70-based PCR-RFLP protocols to clinical samples from the New World.Deep-sequencing revealing mutation dynamics in the miltefosine transporter gene in Leishmania infantum selected for miltefosine resistance.Clinical and parasitological factors in parasite persistence after treatment and clinical cure of cutaneous leishmaniasis.In vitro drug susceptibility of two strains of the wildlife trypanosome, Trypanosoma copemani: A comparison with Trypanosoma cruziEfficacy of tamoxifen and miltefosine combined therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis.
P2860

Treatment failure and miltefosine susceptibility in dermal leishmaniasis caused by Leishmania subgenus Viannia species.

Item
http://www.wikidata.org/entity/Q37544280
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment failure and miltefos ...... ania subgenus Viannia species.
@en
Treatment failure and miltefos ...... ania subgenus Viannia species.
@nl
type
label
Treatment failure and miltefos ...... ania subgenus Viannia species.
@en
Treatment failure and miltefos ...... ania subgenus Viannia species.
@nl
prefLabel
Treatment failure and miltefos ...... ania subgenus Viannia species.
@en
Treatment failure and miltefos ...... ania subgenus Viannia species.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Treatment failure and miltefos ...... mania subgenus Viannia species
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932